Plasma concentration of diclofenac were studied in four healthy women after oral, vaginal, and rectal administration of 100 mg. The area under the concentration time curve (AUC) for diclofenac administration by vaginal route was significantly greater than the AUC after oral administration (4.2 μg·hr/ml and 2.1 μg·hr/ml, respectively), achieving complete bioavailability versus rectal administration. The time to maximal drug plasma concentration (six hours) was also quite different by vaginal route compared with oral (1 to 1.5 hours) or rectal (0.5 to 1 hour) absorption. The obtained results suggest this form of treatment is a valid alternative as far as safety and tolerance are concerned, especially in long-term treatment.

Paroni, R., Fioravanti, A., Fattorini, L., Giordano, N., Borghi, C., Galli Kienle, M., et al. (1991). Bioavailability of diclofenac sodium with vaginal administration in healthy women. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 50(2), 200-204.

Bioavailability of diclofenac sodium with vaginal administration in healthy women

Giordano N.;
1991-01-01

Abstract

Plasma concentration of diclofenac were studied in four healthy women after oral, vaginal, and rectal administration of 100 mg. The area under the concentration time curve (AUC) for diclofenac administration by vaginal route was significantly greater than the AUC after oral administration (4.2 μg·hr/ml and 2.1 μg·hr/ml, respectively), achieving complete bioavailability versus rectal administration. The time to maximal drug plasma concentration (six hours) was also quite different by vaginal route compared with oral (1 to 1.5 hours) or rectal (0.5 to 1 hour) absorption. The obtained results suggest this form of treatment is a valid alternative as far as safety and tolerance are concerned, especially in long-term treatment.
1991
Paroni, R., Fioravanti, A., Fattorini, L., Giordano, N., Borghi, C., Galli Kienle, M., et al. (1991). Bioavailability of diclofenac sodium with vaginal administration in healthy women. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 50(2), 200-204.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/43433
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo